GlobeNewswire

Inspirata Introduces New Artificial Intelligence Tool-Sets for UK Market at European Congress on Digital Pathology

Share

Visit stand 5 at the European Congress on Digital Pathology to explore how Inspirata assists healthcare institutions utilise big-data and artificial intelligence to inform our collective understanding of cancer.

London, UK, April 11, 2019 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata® Europe Ltd today revealed their intention to bring two new artificial intelligence tools for surveillance, structuring and reporting of pathology diagnoses to the UK and Ireland markets.  This announcement coincides with Inspirata’s scheduled participation in the European Congress on Digital Pathology (ECDP), Warwick UK from April 11th-13th 2019.

The two solutions, Abrevio™ and E-Path Reporter, draw on artificial intelligence in the guise of natural language processing (NLP) and are designed to assist healthcare providers normalise and make inferences on the often unstructured and messy clinical notes held in numerous disparate silos within their institution.  While this is the first time Abrevio™ and E-Path Reporter have been made available in the UK and Ireland, the solutions are utilised daily at over 400 institutions across North America and Australia.  Their UK release also comes just weeks after The Topol Review, an independent report commissioned on behalf of the Secretary of State for Health and Social Care, cited natural language processing as one of the top ten healthcare advances projected to have the greatest impact on the National Health Service.  

“The benefits in graduating to digital pathology can typically be grouped into two distinct types,” explains Inspirata EVP & Co-Founder, Dr. Mark Lloyd.  “The first type is the significant operational gains and savings a laboratory will realise in eradicating the inefficiencies which plague the traditional analogue histopathology workflow.  However, the second and arguably more exciting benefits surround the rich data-set generated through digitisation and the opportunity it represents when combined with AI technologies such as NLP to capture and structure additional clinical information.  Together, digital pathology and NLP provide novel and important insights to help inform our understanding of cancer.” 

Mining histopathology big-data represents a near-term priority for many healthcare institutions as typified by Inspirata customer, Ohio State University (OSU), who earlier this year passed a globally significant milestone in successfully amassing an archive of over one million whole slide images.  “We’re looking for answers to some very specific questions,” says Dr. Anil Parwani of OSU and keynote speaker at ECDP. “Embracing digitisation while drawing on new tool-sets predicated on AI to really interrogate the data is the only scalable way for us to realise the kind of downstream advances in patient care we crave.”


Taking their cue from Congress’ thematic focus of accelerating clinical development, Inspirata will also be using ECDP 2019 to spotlight some of the very latest technical partnerships developed since fully opening Dynamyx™, their flagship diagnostics solution, to third-party integrations in May of last year.  “For many institutions being locked into one solution for all aspects of the digital pathology workflow is impractical, unwise and commercially wholly undesirable,” says Inspirata European GM Tim Wing. “It prevents cash-strapped departments from sweating existing hardware investments, while removing the freedom to choose their preferred blend of technologies based on the nuances of their laboratory.  With a promise to entertain integration into Inspirata’s ‘API Garden’ of all relevant providers, we encourage customers to BYO(M)D – bring your own (medical) device.“  The pressures on pathology departments are increasing.  Inspirata’s advanced workflow-centric tools, ‘open’ architecture and focus on the integration of minable information are critical enablers of digital adoption.


Located at stand 5 at European Congress on Digital Pathology, event attendees will be able to participate in interactive demonstrations of Inspirata’s Dynamyx digital pathology workflow software and to discuss how healthcare providers can go ‘beyond digital pathology’ to utilise AI and NLP tools including Abrevio™ and E-Path Reporter.  Abrevio’s™ primary use-case is in auto-abstracting terms from pathology reports and E-Path Reporter is the industry leading automated cancer reporting system.  


About Inspirata Europe Ltd.

Inspirata® Europe Ltd. provides oncology diagnostics workflow solutions that span digital pathology; diagnostic and predictive assays; and precision medicine. It also offers cancer informatics workflows that, in combination with its Natural Language Processing (NLP) and Artificial Intelligence (AI) algorithms structures unstructured case files and clinician notes to provide key insights for oncology-specific clinical and operational activities as well as cancer reporting. Inspirata’s flagship solution is its Cancer Information Data Trust (CIDT) that generates a longitudinal view of oncology patients—from diagnosis, through treatments and therapies, to outcomes. The CIDT has extensive applications in clinical decision support, research, education, drug discovery and clinical trials enrollment. Its use will extend to physicians, patients, researchers, pharma and others. For more information, please visit www.inspirata.com or contact info@inspirata.com.

Attachments

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 201916.7.2019 22:00:00 CESTPress release

LYON, France and CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP) announced that its 2019 Annual General Meeting was held in Paris on Friday, June 21, 2019. At the meeting, all resolutions for which management recommended a vote in favor, were adopted, including: Appointment of Jean-Paul KRESS as director; he was subsequently appointed to the position of Chairman of the Board of Directors; Renewal of the term of office of each of the following as a member of the Board of Directors: o Gil BEYEN; o Luc DOCHEZ; o Philippe ARCHINARD; o Galenos, represented by Sven ANDREASSON; Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2018 and quietus of directors; Allocation of the financial year's results; Approval of regulatory agreements and commitments referred to in Article L.225-38 of the French Commercial Code; Approval of the regulations of the share subscription and/or purchase

LGC Capital Ltd. Announces Change in Financial Year-End16.7.2019 18:30:00 CESTPress release

MONTRÉAL, July 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) wishes to announce that it is changing its financial year-end to December 31 from its current year-end of September 30. As a result, LGC will file an additional interim report as at September 30, 2019 and will report audited financial results for a 15-month transition year from October 1, 2018 to December 31, 2019 (with a comparative of the 12 months ended September 30, 2018). Afterwards, LGC will revert to a customary reporting calendar based on a December 31 year-end, with fiscal quarters ending on the last day of March, June, September and December each year. LGC believes this change of financial year-end will allow it to complete the audit requirements of its investee companies with greater efficiency and will be useful to consolidate other companies in the future. The notice for the change in financial year-end required under Regulation 51-102 respecting Continuous Disclosure Obligations will b

UPDATE -- OneMarket Introduces First Customer Activation Platform Dedicated to Retail16.7.2019 16:53:00 CESTPress release

First-of-its-kind Platform Pairs Data Management and Customer Engagement to Transform How Retailers Monetize Customer Relationships SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- OneMarket (ASX: OMN), today announced the availability of the OneMarket Customer Activation Platform, the first combined data management platform and solutions ecosystem built exclusively to help retailers, brands and venues identify, understand and communicate with customers to build longer-lasting, more profitable relationships. Combining decades of retail and customer lifecycle expertise, OneMarket traces its heritage to the Westfield Corporation and Westfield Labs. As a newly independent entity, OneMarket is leveraging the technological assets and financial investments made under Westfield to bring a turn-key, cloud-based platform technology to market for the benefit of the retail industry. The OneMarket Customer Activation Platform is the company’s first major technology release, purpose-built to addres

OneMarket Introduces First Customer Activation Platform Dedicated to Retail16.7.2019 16:00:00 CESTPress release

First-of-its-kind Platform Pairs Data Management and Customer Engagement to Transform How Retailers SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- OneMarket (ASX: OMN), today announced the availability of the OneMarket Customer Activation Platform, the first combined data management platform and solutions ecosystem built exclusively to help retailers, brands and venues identify, understand and communicate with customers to build longer-lasting, more profitable relationships. Combining decades of retail and customer lifecycle expertise, OneMarket traces its heritage to the Westfield Corporation and Westfield Labs. As a newly independent entity, OneMarket is leveraging the technological assets and financial investments made under Westfield to bring a turn-key, cloud-based platform technology to market for the benefit of the retail industry. The OneMarket Customer Activation Platform is the company’s first major technology release, purpose-built to address the complex customer identific

Agreement with Eurekahedge Expands eVestment’s Hedge Fund Data Offering16.7.2019 14:00:00 CESTPress release

ATLANTA, July 16, 2019 (GLOBE NEWSWIRE) -- eVestment, a global leader in institutional investment data and analytics, today announced an agreement with Eurekahedge to offer Eurekahedge fund data and indices to clients of eVestment’s suite of Analytics solutions. eVestment Analytics clients will now have access to Eurekahedge’s global hedge fund data and indices, which cover over 30,000 hedge funds and funds of hedge funds spanning North American, European, Asian, Latin American and emerging markets. This expansion of data capabilities on the eVestment platform furthers eVestment’s focus on providing the most comprehensive institutional investment data to clients around the world across a wide variety of asset classes, including traditional investment strategies, hedge funds, funds of hedge funds and private markets investment opportunities. “Our clients need the most comprehensive data available to make the best decisions,” said eVestment Global Head of Insights John Molesphini. “Addin

ClarionDoor Adds New Head of Data and Analytics16.7.2019 11:00:00 CESTPress release

Increasing efficiency of data-intensive processes creates deeper need for data scientists by insurers. SANTA BARBARA, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- The explosion of Big Data in the last five to ten years has hit the insurance industry hard due to the inability of legacy technology systems to effectively capture, store, integrate, and utilize unstructured data, in particular, and created an urgent need for data scientists. Forward-thinking insurance industry solution providers, like ClarionDoor, Inc. (ClarionDoor) , developer of enterprise-class, cloud-based rating, quoting, and issuance solutions for property and casualty (P&C) insurers, are adding bench strength with significant data mastery capabilities to help offset the gap for insurance company clients. Notably, ClarionDoor recently added Mark Heslop to the leadership team as the company’s new Head of Data and Analytics. “Mark is an important addition to our team,” said Michael DeGusta, CEO of ClarionDoor. “He will be